PXN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: We previously determined that either NAD+ supplementation or overexpression of Paxillin are sufficient to improve muscle structure and the myomatrix in a zebrafish model of primary dystroglycanopathy.